| Members |
targetComponentId |
| Dalteparin sodium 2500iu/mL injection solution 4mL ampule (product) |
Product containing precisely dalteparin sodium 2500 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Dalteparin sodium 25,000iu/mL injection solution 4mL vial (product) |
Dalteparin sodium 25000 unit/mL solution for injection |
| Dalteparin sodium 25,000iu/mL injection solution 0.4mL prefilled syringe (product) |
Dalteparin sodium 25000 unit/mL solution for injection |
| Dalteparin sodium 25,000iu/mL injection solution 0.5mL prefilled syringe (product) |
Dalteparin sodium 25000 unit/mL solution for injection |
| Dalteparin sodium 25,000iu/mL injection solution 0.6mL prefilled syringe (product) |
Dalteparin sodium 25000 unit/mL solution for injection |
| Dalteparin sodium 25,000iu/mL injection solution 0.72mL prefilled syringe (product) |
Dalteparin sodium 25000 unit/mL solution for injection |
| Danaparoid sodium 750iu/0.6mL injection (product) |
Danaparoid sodium 1250 unit/mL solution for injection |
| Tooth non-tender (situation) |
No pain on tooth percussion (situation) |
| dermatite de contact due à des drogues et/ou des médicaments |
dermatite de contact |
| Contact dermatitis due to ultraviolet rays (excluding sunlight) |
Dermatitis due to exposure to man-made ultraviolet light |
| dermatite de contact due à la lumière, exceptée celle du soleil |
Dermatitis due to exposure to man-made ultraviolet light |
| Autoimmune progesterone dermatitis/urticaria (disorder) |
Menstrual urticaria |
| Autoimmune progesterone dermatitis/urticaria (disorder) |
Autoimmune progesterone dermatitis |
| Dermatophytosis associated with AIDS |
Infection caused by Dermatophyte co-occurrent with human immunodeficiency virus infection (disorder) |
| Dermatophytosis of the body |
Tinea corporis |
| Dermatophytosis of the body |
dermatophytose |
| Irritant contact dermatitis due to incontinence (disorder) |
Irritant contact dermatitis due to contact with urine and/or faeces |
| Desferrioxamine mesylate 2g powder and solvent for injection solution vial (product) |
Deferoxamine mesylate 2 g powder for solution for injection vial |
| Desferrioxamine mesylate 500mg powder and solvent for injection solution vial (product) |
Deferoxamine mesylate 500 mg powder for solution for injection vial |
| destruction unilatérale d'une trompe utérine |
Destruction of left fallopian tube (procedure) |
| destruction unilatérale d'une trompe utérine |
Destruction of right fallopian tube (procedure) |
| Unclassified deuteromycete |
Deuteromycete |
| Diabetes mellitus with hyperosmolar coma |
coma hyperosmolaire associé au diabète sucré |
| Diazoxide 15mg/mL injection solution 20mL ampule (product) |
Diazoxide 15 mg/mL solution for injection |
| Diazepam 5mg/mL injection emulsion 2mL ampule (product) |
Diazepam 5 mg/mL emulsion for injection |
| Diazepam 5mg/mL injection solution 2mL ampule (product) |
Diazepam 5 mg/mL solution for injection |
| Digoxin 100micrograms/1mL pediatric injection (product) |
Digoxin 100 microgram/mL solution for injection |
| Digoxin 250micrograms/mL injection solution 2mL ampule (product) |
Digoxin 250 microgram/mL solution for injection |
| Dimercaprol 50mg/mL injection solution 2mL ampule (product) |
Product containing precisely dimercaprol 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Isosorbide dinitrate 1mg/mL injection solution 10mL ampule (product) |
Isosorbide dinitrate 1 mg/mL solution for injection |
| Isosorbide dinitrate 1mg/mL injection solution 50mL vial (product) |
Isosorbide dinitrate 1 mg/mL solution for injection |
| Isosorbide dinitrate 500micrograms/mL injection solution 50mL vial (product) |
Product containing precisely isosorbide dinitrate 500 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Diphtheria (disorder) |
Diphtheria caused by Corynebacterium diphtheriae (disorder) |
| Dipyridamole 5mg/mL injection solution 2mL ampule (product) |
Dipyridamole 5 mg/mL solution for injection |
| Disopyramide 10mg/mL injection solution 5mL ampule (product) |
Disopyramide (as disopyramide phosphate) 10 mg/mL solution for injection |
| dispositif intra-utérin |
Intrauterine contraceptive device (physical object) |
| dispositif intra-utérin |
forme pharmaceutique intra-utérine |
| divers facteurs de risque pour le bébé |
Risk factor |
| Baby miscellaneous "at-risk" factors |
enfant à risque |
| division unilatérale d'une trompe utérine |
Division of right fallopian tube |
| division unilatérale d'une trompe utérine |
Division of left fallopian tube (procedure) |
| Atomic power plant malfunction in watercraft, water skier injured (event) |
Atomic power plant malfunction in watercraft (event) |
| Defective development of the cauda equina |
Congenital anomaly of cauda equina |
| Microcephalic osteodysplastic dysplasia (disorder) |
Microcephalic osteodysplastic dysplasia Saul Wilson type (disorder) |
| dystrophie congénitale des aponévroses |
Stiff skin syndrome |
| Flupentixol decanoate 100mg/mL injection solution 0.5mL ampule (product) |
Product containing precisely flupentixol decanoate 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Flupenthixol decanoate 100mg/mL injection solution 1mL ampule (product) |
Product containing precisely flupentixol decanoate 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Flupentixol decanoate 20mg/mL injection solution 1mL ampule (product) |
Flupentixol decanoate 20 mg/mL solution for injection |
| Flupentixol decanoate 20mg/mL injection solution 2mL ampule (product) |
Flupentixol decanoate 20 mg/mL solution for injection |
| Flupentixol decanoate 200mg/mL injection solution 1mL ampule (product) |
Product containing precisely flupentixol decanoate 200 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Fluphenazine decanoate 100mg/mL injection solution 0.5mL ampule (product) |
Fluphenazine decanoate 100 mg/mL solution for injection |
| Fluphenazine decanoate 100mg/mL injection solution 1mL ampule (product) |
Fluphenazine decanoate 100 mg/mL solution for injection |
| Fluphenazine decanoate 25mg/mL injection solution 0.5mL ampule (product) |
Product containing precisely fluphenazine decanoate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Fluphenazine decanoate 25mg/mL injection solution 1mL ampule (product) |
Product containing precisely fluphenazine decanoate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Fluphenazine decanoate 25mg/mL injection solution 2mL ampule (product) |
Product containing precisely fluphenazine decanoate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Fluphenazine decanoate 25mg/mL injection solution 10mL vial (product) |
Product containing precisely fluphenazine decanoate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Fluphenazine decanoate 25mg/mL injection solution 1mL prefilled syringe (product) |
Product containing precisely fluphenazine decanoate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Fluphenazine decanoate 25mg/mL injection solution 2mL prefilled syringe (product) |
Product containing precisely fluphenazine decanoate 25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Zuclopenthixol decanoate 200mg/mL injection solution 1mL ampule (product) |
Zuclopenthixol decanoate 200 mg/mL solution for injection |
| Zuclopenthixol decanoate 500mg/mL injection solution 1mL ampule (product) |
Zuclopenthixol decanoate 500 mg/mL solution for injection |
| Death of partner |
Partner deceased (situation) |
| Death occurring less than 24 hours from onset of symptoms, not otherwise expected (event) |
Death in less than 24 hours from onset of symptoms |
| Death occurring less than 24 hours from onset of symptoms, not otherwise expected (event) |
Unexpected death (event) |
| Hydropic degeneration |
Hydropic degeneration of chorionic villi |
| Screened - abnormality |
Abnormal finding on screening procedure (finding) |
| déplacement d'un véhicule impliqué dans un accident |
accident de véhicule |
| Other materials moving/storing |
Transporting/moving/storing |
| Derailment due to train problem, without antecedent collision, pedal cyclist injured (event) |
Derailment due to train problem, without antecedent collision (event) |
| Derailment due to train problem, without antecedent collision, pedestrian injured (event) |
Derailment due to train problem, without antecedent collision (event) |
| déraillement dû à un problème de voie sans une collision antérieure, cycliste blessé |
Derailment due to track problem without antecedent collision (event) |
| Derailment due to track problem, without antecedent collision, pedestrian injured (event) |
Derailment due to track problem without antecedent collision (event) |
| Cholinesterase genotype determination (procedure) |
Butyrylcholinesterase genotype determination (procedure) |
| Vertical spinal deviation |
déformation scoliotique de la colonne vertébrale |
| Vertical spinal deviation |
Curvature of spine |
| Bruise of head |
Contusion of head (disorder) |
| eczéma vésiculaire des mains et/ou des pieds |
Podopompholyx |
| Miscellaneous topical preparations adverse reaction (navigational concept) |
Topical agent adverse reaction (disorder) |
| Adverse reaction caused by typhoid and paratyphoid vaccines (disorder) |
Adverse reaction to paratyphoid vaccine |
| Adverse reaction caused by typhoid and paratyphoid vaccines (disorder) |
effet indésirable du vaccin contre la typhoïde |
| Adverse reaction to mixed bacterial vaccine |
effet indésirable aux vaccins bactériens |
| Adverse effect of correct biological substance after proper administration (disorder) |
Adverse reaction to biological substance |
| Adverse effect, caused by correct medicinal substance properly administered (disorder) |
effet indésirable d'un médicament |
| Toxic effect of metal |
intoxication causée par un métal et/ou un composé métallique (trouble) |
| Toxic effect of gas, fumes AND/OR vapors (disorder) |
intoxication causée par une substance gazeuse |
| Toxic effect of gas, fumes AND/OR vapors (disorder) |
Poisoning by fumes |
| Embolism and thrombosis of an arm or leg artery |
Thromboembolus of artery of upper limb |
| Embolism and thrombosis of an arm or leg artery |
Thromboembolus of artery of lower limb |
| Catheter and cannula tip |
Cannula tip submitted as specimen (specimen) |
| Catheter and cannula tip |
Catheter submitted as specimen (specimen) |
| encéphalite causée par la grippe, virus identifié |
Encephalitis caused by influenza (disorder) |
| encéphalite causée par la grippe, virus spécifique non identifié |
Encephalitis caused by influenza (disorder) |
| encéphalographie demandée |
radiologie demandée |
| Education of guardian (situation) |
Educational level of guardian of subject (observable entity) |
| Education of guardian (situation) |
Educating guardian of subject (situation) |
| Education of parent (situation) |
Educational level of parent of subject |
| Education of parent (situation) |
Educating parent of subject (situation) |
| enseignement, directives et counseling |
Counselling |
| enseignement, directives et counseling |
Education |
| Ostomy care education, guidance, and counseling (procedure) |
Ostomy care education |
| Social work/counseling education, guidance, and counseling (procedure) |
Social therapy (regime/therapy) |
| Tumor measureable (observable entity) |
Neoplasm observable |
FHIR